Emirates Drug Establishment approves world’s first oral therapy for immune thrombocytopenia
Emirates Drug Establishment approves world’s first oral therapy for immune thrombocytopenia[original_title] The Emirates Drug Establishment (EDE) has granted official approval for Rilzabrutinib, the first oral Bruton’s tyrosine kinase (BTK) inhibitor to be authorised in the country for the treatment of...